DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma - Related Studies

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

This study is ongoing, but not recruiting participants.

Study NCT00080834. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer

2	Additional conditions recognized in this trial
		Adenocarcinoma
		Colorectal Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Rectal Diseases

4	Interventions listed in this trial
		DJ-927

5	Sponsors listed in this trial
		Daiichi Sankyo Inc.